Exparel liposomal Evrópusambandið - íslenska - EMA (European Medicines Agency)

exparel liposomal

pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

Procamidor vet. Stungulyf, lausn 20 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

procamidor vet. stungulyf, lausn 20 mg/ml

vetviva richter gmbh - procainum hýdróklóríð - stungulyf, lausn - 20 mg/ml

Mepidor vet. Stungulyf, lausn 20 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

mepidor vet. stungulyf, lausn 20 mg/ml

vetviva richter gmbh - mepivacainum hýdróklóríð - stungulyf, lausn - 20 mg/ml

Tagrisso Evrópusambandið - íslenska - EMA (European Medicines Agency)

tagrisso

astrazeneca ab - osimertinib mesilate - krabbamein, lungnakrabbamein - Önnur antineoplastic lyf, prótín nt-hemlar - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.

Detonervin vet. 10 mg/ml stungulyf, lausn fyrir hesta og nautgripi. (Detonervin handa hestum og nautgripum) Stungulyf, lausn Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

detonervin vet. 10 mg/ml stungulyf, lausn fyrir hesta og nautgripi. (detonervin handa hestum og nautgripum) stungulyf, lausn

le vet b.v.* - detomidinum hýdróklóríð - stungulyf, lausn

Synthadon vet. Stungulyf, lausn 10 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

synthadon vet. stungulyf, lausn 10 mg/ml

le vet beheer b.v. - methadonum hýdróklóríð - stungulyf, lausn - 10 mg/ml

Rybrevant Evrópusambandið - íslenska - EMA (European Medicines Agency)

rybrevant

janssen-cilag international n.v.    - amivantamab - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Detrusitol Retard Hart forðahylki 2 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

detrusitol retard hart forðahylki 2 mg

upjohn eesv - tolterodinum l-tartrat - hart forðahylki - 2 mg

Detrusitol Retard Hart forðahylki 4 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

detrusitol retard hart forðahylki 4 mg

upjohn eesv - tolterodinum l-tartrat - hart forðahylki - 4 mg

Zenalpha Evrópusambandið - íslenska - EMA (European Medicines Agency)

zenalpha

vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psycholeptics, svefnlyf og róandi lyf - hundar - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.